Las Vegas, NV -- (SBWIRE) -- 12/03/2012 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume movers as reported by http://beststocksdaily.com/
Hemispherx BioPharma, Inc (NYSEAMEX:HEB) is currently trading at $0.792, 2.82% higher. Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
Can HEB Jump Again? Find Out Here http://beststocksdaily.com/p2/index.php?company=HEB
New Gold Inc. (USA) (NYSEAMEX:NGD) added 1.60% to $10.80. New Gold Inc. is engaged in gold mining and related activities, including acquisition, exploration, extraction, processing and reclamation. Its operating assets consist of the Mesquite gold mine (Mesquite Mine) in the United States, the Cerro San Pedro gold-silver mine (Cerro San Pedro Mine) in Mexico, and the Peak gold-copper mines in Australia.
Get Free Trend Analysis on NGD Here http://beststocksdaily.com/p2/index.php?company=NGD
Cardium Therapeutics Inc (NYSEAMEX:CXM) is higher 4.17% to $0.225. Cardium Therapeutics, Inc. (Cardium) is focused on the acquisition and strategic development of product opportunities or businesses having the potential to address unmet medical needs. With additional products and distribution channels, the Company plans to develop MedPodium into a portfolio of science-based, easy to use medicinals, neurologics, metabolics, nutraceuticals and aesthetics intended to promote and manage personal health.
To Get complete technical analysis on CXM go to http://beststocksdaily.com/p2/index.php?company=CXM
CEL-SCI Corporation (NYSEAMEX:CVM) among the gainers and the stock jumped 4.38% to $0.355. CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
Get Free Trend Analysis on CVM Here http://beststocksdaily.com/p2/index.php?company=CVM
Vantage Drilling Company (NYSEAMEX:VTG) is currently trading at $1.89, 5% higher. Vantage Drilling Company (Vantage Drilling) is an international offshore drilling company focused on operating a fleet of drilling units. The Company’s primary business is to contract drilling units, related equipment and work crews primarily on a dayrate basis to drill oil and natural gas wells for its customers.
To Get complete technical analysis on VTG go to http://beststocksdaily.com/p2/index.php?company=VTG
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)